Jefferies has reiterated its Buy rating on Apollo Hospitals, setting a target price of ₹8,140, suggesting a 9.9% upside from the current market price of ₹7,409.95. Apollo Hospitals reported a strong overall performance, exceeding Jefferies’ estimates. The hospital division achieved multi-quarter high occupancy levels, while HealthCo’s profitability continued to improve, meeting growth expectations.
The company’s focus on strategic growth areas has contributed significantly to its consistent performance, with Jefferies noting Apollo’s effectiveness in delivering on its growth objectives.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult your financial advisor before making any investment decisions.
